TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SinoMab Bioscience Ltd. ( (HK:3681) ) has shared an update.
SinoMab BioScience Ltd. announced the results of its Annual General Meeting held on June 30, 2025, where all proposed resolutions, except one that was withdrawn, were approved by shareholders. The resolutions included the re-election of directors, authorization for directors’ remuneration, re-appointment of auditors, and mandates for share buybacks and issuance, indicating strong shareholder support and strategic alignment in the company’s governance and operational plans.
More about SinoMab Bioscience Ltd.
SinoMab BioScience Ltd. is a biotechnology company based in Hong Kong, focusing on the development and commercialization of therapeutics for the treatment of immunological diseases.
Average Trading Volume: 9,430,161
Technical Sentiment Signal: Buy
Current Market Cap: HK$2.28B
For an in-depth examination of 3681 stock, go to TipRanks’ Overview page.